Achalasia
80
13
15
32
Key Insights
Highlights
Success Rate
78% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.3%
9 terminated out of 80 trials
78.0%
-8.5% vs benchmark
10%
8 trials in Phase 3/4
6%
2 of 32 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 32 completed trials
Clinical Trials (80)
Disposable Endoscope Platform in Third Space Endoscopic Procedures
Comprehensive Esophageal Diagnostics Study
Botox or Botox With Esophageal Dilation in Patients With Achalasia
Impact of Body Positioning on EndoFLIP Measurements: A Comparative Study of Supine and Left Lateral Decubitus Positions
Autonomic Dysfunction and Hemodynamic Instability During Per-oral Endoscopic Myotomy
Clinical Outcomes, Safety, and Effectiveness of Speedboat UltraSlim™ in Per-Oral Endoscopic Myotomy (POEM)
Peroral Endoscopic Myotomy for the Treatment of Achalasia
Mechanisms of Weight Loss in Patients Diagnosed With Achalasia
VZV in the Enteric Nervous System: Pathogenesis and Consequences
PRospective Registry of Esophageal Motility
POEM Trial: Multi-center Study Comparing Endoscopic Pneumodilation and Per Oral Endoscopic Myotomy (POEM)
Per-Oral Endoscopic Myotomy (POEM) for the Treatment of Achalasia, Database Repository
Safety and Efficacy of a Novel SpydrBlade Flexible Bipolar in POEM
Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy for Gastrointestinal Motility Disorders
Minimally Invasive Surgery of the Gastro-esophageal Junction
Outcome Analysis of POEM and Endoluminal Therapies
POEM- Peroral Endoscopic Myotomy for Esophageal Motility Disorders
The Use of Indocyanine Green Fluorescence (ICG) During Laparoscopic Heller- Dor
Electrosurgical Modes for Endoscopic Submucosal Dissection in Peroral Endoscopic Esophageal Myotomy
ARAT for Reflux Disease After Peroral Endoscopic Myotomy in Patients With Achalasia